Innovations & Thérapeutiques en Oncologie
MENUDermatomyositis, hepatitis Band ovarian cancer. Association or coincidence: a case study Volume 8, issue 5, September-October 2022
Authors
1 Hôpital universitaire Mohammed IV, Service d’oncologie médicale, Avenue Ibn Sina, Marrakech, Maroc. <kawtar.elbouaouidi13@gmail.com>
2 CHU Hassan II, Service d’oncologie médicale, Route de Sidi Harazem, Fès, Maroc. <drzouitenothmane@gmail.com>
3 Institut national d’oncologie, Service d’oncologie médicale, BP 6213 RI, Rabat, Maroc. <afanileila@gmail.com>
* Tirés à part : K. El Bouaouidi
Remerciements et autres mentions :
Financement : aucun.
Liens d’intérêts : les auteurs n’ont pas déclaré leurs potentiels liens d’intérêts.
- Key words: dermatomyositis, hepatitis B, cancer, ovary
- DOI : 10.1684/ito.2022.0335
- Page(s) : 267-70
- Published in: 2022
Dermatomyositis is an autoimmune disease of idiopathic origin, which manifests with heterogeneous signs, dominated by those that are cutaneous. It is a rare pathology, and the diagnosis prompts investigation for an associated cancer, in particular, lymphoma or ovarian cancer. Dermatomyositis is often associated with a viral infection and has been identified in patients infected with viral hepatitis B, however, there is no direct histological evidence of an association between the two.
We report the case of a 68-year-old patient followed for dermatomyositis, diagnosed with viral hepatitis B and ovarian cancer.